Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Deininger

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Haematologica|August 2, 2013
What challenges remain in chronic myeloid leukemia research?Angelo M Carella, Susan Branford, Michael Deininger, et al.
Leukemia Research|April 4, 2007
Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitorsFei Bao, Paula Polk, Mary L Nordberg, et al.
Seminars in Oncology|May 3, 2008
Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemiaFrancis J Giles, Daniel J DeAngelo, Michele Baccarani, et al.
British Journal of Haematology|March 12, 2011
Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemiaThomas Ernst, Joannah Score, Michael Deininger, et al.
Nature Communications|October 29, 2020
Inter-hemispheric synchroneity of Holocene precipitation anomalies controlled by Earth's latitudinal insolation gradientsMichael Deininger, Frank McDermott, Francisco W Cruz, et al.
Cancer Research|October 19, 2005
Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compoundsKarl J Aichberger, Matthias Mayerhofer, Maria-Theresa Krauth, et al.
Plos One|August 31, 2017
The earliest settlers of Mesoamerica date back to the late PleistoceneWolfgang Stinnesbeck, Julia Becker, Fabio Hering, et al.
Leukemia Research|March 9, 2019
Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinibAaron T Gerds, Tetsuzo Tauchi, Ellen Ritchie, et al.
Leukemia Research|April 29, 2019
Corrigendum to "Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib" [Leukemia Res. 79 (2019) 38-44]Aaron T Gerds, Tetsuzo Tauchi, Ellen Ritchie, et al.
Leukemia|October 4, 2023
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemiaNicholas C P Cross, Thomas Ernst, Susan Branford, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Haematologica|August 2, 2013
What challenges remain in chronic myeloid leukemia research?Angelo M Carella, Susan Branford, Michael Deininger, et al.
Leukemia Research|April 4, 2007
Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitorsFei Bao, Paula Polk, Mary L Nordberg, et al.
Seminars in Oncology|May 3, 2008
Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemiaFrancis J Giles, Daniel J DeAngelo, Michele Baccarani, et al.
British Journal of Haematology|March 12, 2011
Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemiaThomas Ernst, Joannah Score, Michael Deininger, et al.
Nature Communications|October 29, 2020
Inter-hemispheric synchroneity of Holocene precipitation anomalies controlled by Earth's latitudinal insolation gradientsMichael Deininger, Frank McDermott, Francisco W Cruz, et al.
Cancer Research|October 19, 2005
Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compoundsKarl J Aichberger, Matthias Mayerhofer, Maria-Theresa Krauth, et al.
Plos One|August 31, 2017
The earliest settlers of Mesoamerica date back to the late PleistoceneWolfgang Stinnesbeck, Julia Becker, Fabio Hering, et al.
Leukemia Research|March 9, 2019
Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinibAaron T Gerds, Tetsuzo Tauchi, Ellen Ritchie, et al.
Leukemia Research|April 29, 2019
Corrigendum to "Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib" [Leukemia Res. 79 (2019) 38-44]Aaron T Gerds, Tetsuzo Tauchi, Ellen Ritchie, et al.
Leukemia|October 4, 2023
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemiaNicholas C P Cross, Thomas Ernst, Susan Branford, et al.
Pageof 8